Ngā hua rapu - Xiaomin Wan
- E whakaatu ana i te 1 - 4 hua o te 4
-
1
First‐line atezolizumab in addition to bevacizumab plus chemotherapy for metastatic, nonsquamous non–small cell lung cancer: A United States–based cost‐effectiveness analysis... mā Xiaomin Wan, Xia Luo, Chongqing Tan, Xiaohui Zeng, Yucong Zhang, Liubao Peng
I whakaputaina 2019Artigo -
2
Overexpression of Mitochondrial Phosphate Transporter 3 Severely Hampers Plant Development through Regulating Mitochondrial Function in Arabidopsis mā Fengjuan Jia, Xiaomin Wan, Wei Zhu, Dan Sun, Chengchao Zheng, Pei Liu, Jinguang Huang
I whakaputaina 2015Artigo -
3
-
4
Cost-Effectiveness of First-Line Versus Second-Line Pembrolizumab or Chemotherapy in Patients With Microsatellite-Instability-High/Mismatch Repair-Deficient Advanced Colorectal Can... mā Chongqing, Tan, Sini, Li, Xiaohui, Zeng, Liubao, Peng, Ye, Peng, Shuxia, Qin, Liting, Wang, Meiyu, Wu, Xiaomin, Wan
I whakaputaina 2021Text
Ngā utauta rapu:
Ngā marau whai pānga
Cancer
Immunotherapy
Internal medicine
Lung cancer
Medicine
Oncology
Alternative oxidase
Arabidopsis
Arabidopsis thaliana
Atezolizumab
Bevacizumab
Biochemistry
Biology
Carboplatin
Cell biology
Cellular respiration
Chemotherapy
Cisplatin
Cost effectiveness
Cytosol
Docetaxel
Enzyme
Gene
Intensive care medicine
Mitochondrion
Mutant
Nivolumab
Organelle
Paclitaxel
Pembrolizumab